ClinicalTrials.govpublic full text
A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients
non-squamous non-small cell lung cancer (nsclc), advanced non squamous nsclc, advanced non-squamous non small cell lung cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836077
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.